LenioBio, AffinityAI team up on AI-driven protein design
LenioBio GmbH at the moment introduced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration combines LenioBio’s proprietary cell-free protein expression platform, ALiCE®, with AffinityAI’s superior design engine, Designerbodies, to considerably speed up the invention and optimization de novo proteins. By integrating AI-guided protein design with high-throughput cell-free expression, the partnership closes the…
